MedTrace Logo

Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

NCT02034656 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2014-01-13

No results posted yet for this study

Summary

The purposes of this study are to investigate the patterns of BCR-ABL mutations in CML and Ph positive ALL patients with imatinib resistance during the year of 2001-2009 in Asian institutes.

Conditions

  • Chronic Myeloid Leukemia or Ph Positive ALL

Sponsors & Collaborators

Principal Investigators

  • Dong-Wook Kim, MD, PhD · Seoul St. Mary's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2014-03-31
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034656 on ClinicalTrials.gov